YS Biopharma Co, Analysis
YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma Co, is overvalued with Real Value of 0.46 and Hype Value of 0.48. The main objective of YS Biopharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what YS Biopharma Co, is worth, separate from its market price. There are two main types of YS Biopharma's stock analysis: fundamental analysis and technical analysis.
The YS Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. YS Biopharma is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. YS Biopharma Stock trading window is adjusted to America/New York timezone.
YS Biopharma |
YS Biopharma Stock Analysis Notes
About 81.0% of the company outstanding shares are owned by insiders. The book value of YS Biopharma was at this time reported as 5.1. The company recorded a loss per share of 0.56. YS Biopharma Co, had not issued any dividends in recent years. For more information please call Hui Shao at 86 10 8920 2086 or visit https://www.ysbiopharm.com.YS Biopharma Co, Investment Alerts
YS Biopharma Co, is now traded under the symbol LSB. Please update your portfolios or report it if you believe this is an error. Report It! | |
YS Biopharma Co, is not yet fully synchronised with the market data | |
YS Biopharma Co, has some characteristics of a very speculative penny stock | |
YS Biopharma Co, has a very high chance of going through financial distress in the upcoming years | |
The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0. | |
YS Biopharma generates negative cash flow from operations | |
About 81.0% of the company outstanding shares are owned by insiders |
YS Biopharma Co, Upcoming and Recent Events
22nd of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of March 2023 Last Financial Announcement | View |
YS Biopharma Market Capitalization
The company currently falls under 'Small-Cap' category with a market capitalization of 192.09 M.YS Biopharma Profitablity
The company has Net Profit Margin (PM) of (0.67) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.49) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.49.YS Biopharma Predictive Daily Indicators
YS Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of YS Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding YS Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |